Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. a Prospective Multicenter Nationwide Study. (ENDOBIO)

NCT05339451 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT05339451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05339451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. a Prospective Multicenter Nationwide Study. (ENDOBIO)
Lead sponsor
Region Stockholm
Phase
Observational
Overall status
Recruiting
Start date
May 4, 2023
Completion date
December 31, 2026
Enrollment
345 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis